Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 6NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 40Breast Neoplasms, Male 12Urinary Bladder Neoplasms 5Stomach Neoplasms 5Rectal Neoplasms 5Pancreatic Neoplasms 5Inflammatory Breast Neoplasms 5Esophageal Neoplasms 5Endometrial Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Uterine Cervical Neoplasms 3Urethral Neoplasms 3Thyroid Neoplasms 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Gallbladder Neoplasms 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Bile Duct Neoplasms 3Vulvar Neoplasms 2Vipoma 2Vaginal Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Testicular Neoplasms 2

Interventions

Doxorubicin 3Dexrazoxane 3Cyclophosphamide 3Razoxane 2Neoadjuvant Therapy 2Filgrastim 2oblimersen 1Trastuzumab 1Taxes 1Tamoxifen 1Radiotherapy 1Radiation 1Paclitaxel 1Methotrexate 1Leucovorin 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Epirubicin 1Docetaxel 1Cisplatin 1Chemotherapy, Adjuvant 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Cardiotoxicity × Trastuzumab × Clear all
NCT00016276 2013-01-16

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 3 Terminated
396 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡